Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

clinical trial

Details

Instance of: clinical trial
Start time: August 2010
End time: November 2013
Country: United States
Main subject: hematopoietic system disease, myelodysplastic syndrome, leukemia, anemia
clinical trial phase: phase II clinical trial
number of participants: 7
research site: University of Texas at Houston Police Department
study type: interventional study
title: Phase II Pilot Study Of Alemtuzumab In Patients With Low Or INT-1 Risk Myelodysplastic Syndrome (MDS), Aplastic Anemia (AA), Or T-Cell Large Granular Lymphocytic Leukemia (T-LGL)

Nothing in the MetaHistoryBook collection references this item yet.